Cellectar biosciences stock split uutnbhm

Cellectar biosciences stock split

01.12.2020

Drews39095

Cellectar Biosciences, Inc. (CLRB) Split History | Seeking ... See Cellectar Biosciences, Inc. (CLRB) history of stock splits. Includes date and ratio. Cellectar Biosciences, Inc. Common Stock (CLRB) Financials Find the latest Financials data for Cellectar Biosciences, Inc. Common Stock (CLRB) at Nasdaq.com. Cellectar Biosciences, Inc. (CLRB) Stock Forum ... Find the latest Cellectar Biosciences, Inc. (CLRB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Cellectar Biosciences Announces 1-for-10 Reverse Stock Split

Get Cellectar Biosciences Inc (CLRB:NASDAQ) real-time stock quotes, news and financial information from CNBC.

Cellectar Biosciences issues reserve stock split | Madison ... Jul 14, 2018 · Cellectar Biosciences, a publicly-traded Madison biopharmaceutical company working on cancer treatments, enacted a 10-for-1 reverse stock split on Friday, effective at the close of business for the day. That means for every 10 shares of Cellectar's common stock, holders will own 1 share, reducing the number of outstanding common shares from 18

CLRB: Cellectar Biosciences, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Cellectar Biosciences, Inc. from Zacks Investment Research

Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Data :: Cellectar Biosciences, Inc. (CLRB) Cellectar Biosciences, Inc. Home; About. Overview ; Partnerships ; Management Team Cellectar Biosciences, Inc. (CLRB) Split History | Seeking ...

Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ...

Stock split history for Cellectar Biosciences since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Cellectar says tumors shrank as much as 90 percent in ... Aug 12, 2018 · Cellectar Biosciences, a Madison company working on cancer-fighting medications, is cheering early patient test results of its main compound, but it has ended production of the drug here, cutting jobs, and last week the company learned its supply of the drug has been temporarily halted by federal regulators. Cellectar Biosciences issues reserve stock split | Madison ... Jul 14, 2018 · Cellectar Biosciences, a publicly-traded Madison biopharmaceutical company working on cancer treatments, enacted a 10-for-1 reverse stock split on Friday, effective at the close of business for the day. That means for every 10 shares of Cellectar's common stock, holders will own 1 share, reducing the number of outstanding common shares from 18 Cellectar Biosciences Stock Quote: CLRB Stock News, Quotes ...

Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer.

Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ... Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update. FLORHAM PARK, N.J., March 09, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and. Stock Splits - The Online Investor Mar 13, 2020 · Direxion Shares Exchange Traded Fund Trust - Latin America Bull 3X Shares is an open-end manament investment company. The Fund seeks daily investment results, before fees and expenses that correspond to the S&P Latin America 40 Index. CLRB: Cellectar Biosciences Inc - Stock Price ... - CNBC Get Cellectar Biosciences Inc (CLRB:NASDAQ) real-time stock quotes, news and financial information from CNBC.